Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as ...

“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...

STARING at yet another pregnancy test, Erica Coronado was thrilled but terrified. The 36-year-old had given up hope of a baby ...

WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

There have been warnings that weight loss drugs such as Ozempic and Hugo Bee could reduce the effectiveness of contraceptives ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...